MSX-122: Is an effective small molecule CXCR4 antagonist in cancer therapy?
•CXCL12/CXCR4 axis is involved in tumor cell proliferation, survival, and metastasis.•MSX-122 as a CXCR4 inhibitor can be effective in cancer therapy.•MSX-122 can increase the sensitivity of tumor cells to chemotherapy. Chemokines, a subgroup of cytokines along with their receptors, are involved in...
Gespeichert in:
Veröffentlicht in: | International immunopharmacology 2022-07, Vol.108, p.108863-108863, Article 108863 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!